Nital M. Rami has over 10 years of experience in quality assurance roles in the pharmaceutical industry. She is currently a Senior Quality Assurance Associate at Pharmaceutics International Incorporated, where she reviews batch records and analytical reports to ensure compliance and expedite product release or rejection. Previously, she held quality assurance roles at Shire Pharmaceuticals and served as a Quality Engineer, Quality Assurance Associate, and Process Operator. She has extensive experience with various manufacturing equipment and processes.
Regulatory aspect of pharmaceutical change control systemDeveshDRA
CHANGE CONTROL,BENEFITS OF CHANGE CONTROL SYSTEM,MANAGEMENT OF CHANGE AND CONTINUOUS IMPROVEMENT(Prepare a Change Proposal,Classify & Approve Proposed Changes,Develop an Implementation Plan, Install the Change,Verify Installation,Close out the change
) FLOW CHART OF CHANGE MANAGEMENT,HANDLING AND CONTROLLING CHANGES,SOP ON CHANGE CONTROL SYSTEM,
CATEGORY OF CHANGES(Major Changes,Moderate changes,Minor changes),ENSURING TRAINING & PROCEDURES IN A MANAGEMENT OF CHANGE PROGRAM,LEVEL OF APPROVAL,REGULATOR PROSPECTIVE OF CHANGE CONTROL(21 CFR Part 211: Sec. 211.100,21 CFR Part 211.194 (Laboratory Records),ICH Q7A,USFDA Guidance for Industry: Change to an approved NDA or ANDA ( April 2004- Revison-1)),CONCLUSION
,
Establishing integrated end-to-end processes is a top priority for many companies. However, most have disconnected sourcing, purchasing, and accounts payable processes. This creates challenges such as decreased efficiency and reduced stakeholder satisfaction.
Building a procure-to-pay process with a well-defined strategy and governance can provide your company with the foundation to realize significant benefits such as reduced staffing levels, improved liquidity, and increased savings. To learn more about how to adopt leading procure-to-pay practices, please visit www.scottmadden.com or contact us at info@scottmadden.com.
the difference between quality control and quality assurance. the main difference is quality assurance is process oriented and makes sure you are doing the right things, the right way. while quality control is product oriented and makes sure the results of what you have done are what you expected
Regulatory aspect of pharmaceutical change control systemDeveshDRA
CHANGE CONTROL,BENEFITS OF CHANGE CONTROL SYSTEM,MANAGEMENT OF CHANGE AND CONTINUOUS IMPROVEMENT(Prepare a Change Proposal,Classify & Approve Proposed Changes,Develop an Implementation Plan, Install the Change,Verify Installation,Close out the change
) FLOW CHART OF CHANGE MANAGEMENT,HANDLING AND CONTROLLING CHANGES,SOP ON CHANGE CONTROL SYSTEM,
CATEGORY OF CHANGES(Major Changes,Moderate changes,Minor changes),ENSURING TRAINING & PROCEDURES IN A MANAGEMENT OF CHANGE PROGRAM,LEVEL OF APPROVAL,REGULATOR PROSPECTIVE OF CHANGE CONTROL(21 CFR Part 211: Sec. 211.100,21 CFR Part 211.194 (Laboratory Records),ICH Q7A,USFDA Guidance for Industry: Change to an approved NDA or ANDA ( April 2004- Revison-1)),CONCLUSION
,
Establishing integrated end-to-end processes is a top priority for many companies. However, most have disconnected sourcing, purchasing, and accounts payable processes. This creates challenges such as decreased efficiency and reduced stakeholder satisfaction.
Building a procure-to-pay process with a well-defined strategy and governance can provide your company with the foundation to realize significant benefits such as reduced staffing levels, improved liquidity, and increased savings. To learn more about how to adopt leading procure-to-pay practices, please visit www.scottmadden.com or contact us at info@scottmadden.com.
the difference between quality control and quality assurance. the main difference is quality assurance is process oriented and makes sure you are doing the right things, the right way. while quality control is product oriented and makes sure the results of what you have done are what you expected
This article will provide clarity on all below mentioned points,
FDA Audit - The Do and Don't List
How to Prepare for a FDA Inspection
FDA Basics for Industry > What should I expect during an inspection?
What to Expect When Being Inspected - FDA
FDA Inspections: Face the Challenge Through Proactive PreparationTips to Help You Prepare for an FDA Inspection
Inspection Readiness
US food and drug administration Indian site inspections: An experience
Dealing with a "difficult" FDA investigator
Strategies For Managing FDA Inspection Compliance Risks
Dear Readers,
Through PRES we are trying to connect with the Global Pharma community. Where we discussed, share and explore lots of pharmaceutical hot topics. Being a Pharma professional it is very difficult to get time for own to do something different other than routine responsibilities. Hope you all paraprofessionals are agreed with my views.
That’s you, the readers and followers of my blog, who always encouraged me a lot to do something different than my routine schedule. All the information are easily available web media, I am just trying too collate all those information in a single article.
I have collated the information’s broadly from the Pharmacompliancemonitor, FDA and other regulatory website for this article.
Once again I would like to thanks my readers, followers and seniors, who has encourage me a lot.
PRES Mission
To develop scientifically sound, practical, technical information and resources to advance science and regulation for the pharmaceutical industry
PRES Vision
To be the foremost global provider of science, technology, and regulatory information and education for the pharmaceutical community
Change Management in Pharmaeutical Manufacturing Operations (Full Day Session)Obaid Ali / Roohi B. Obaid
InshaAllah will be delivered tomorrow (04 Aug 2018) in a workshop of about 30 participants (Professionals engaged in Pharmaceutical Manufacturing, Engineering, Regulatory & Quality Operations)
A structured approach to the investigation process should be used with the objective of determining the root cause.
The level of effort, formality, and documentation of the investigation should be commensurate with the level of risk, in line with ICH Q9.
Managing Process Scale-up and Tech Transfer MilliporeSigma
Are you involved with planning tech transfer of your drug product? Join this webinar to learn more about the regulations and considerations you need to consider and learnings from a case study.
According to ICH Q10, “The goal of technology transfer activities is to transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realization. This knowledge forms the basis for the manufacturing process, control strategy, process validation approach, and ongoing continual improvement.”
As a result, there is an expectation for transfers to be performed in an organized, methodical manner with appropriate documentation. It is also expected that they happen between one Process Development group to another or to a Pilot Lab, from Process Development lab to clinical or commercial manufacturing, or from Process Development to external clinical manufacturing. Lastly, they may also happen between two company facilities at commercial scale, or between a company and an external contract manufacturing at commercial scale.
This presentation will cover points to consider for successful tech transfers with a focus on cGMP training requirements, and include lesson learned from real cases.
Presented by Guillaume Plane on September 22, 2016
Quality Management system in accordance to Vol. 4 EU Guidelines for GMP for Medicinal Products for Human and Veterinary Use Chapter 1 Pharmaceutical QS
ICH Q10/ Q7.
ISO 9001/2015
The 10 Most Important Levers of Control That All Product Managers and Product...CompellingPM
Way too often, Product Managers & Product Marketers make the excuse that they cannot take ownership for the success of their product in the market because there are too many factors outside to their control. While many Product Managers/Marketers complain about these limitations, Great Product Managers & Marketers become Strategic and take ownership of the success of their products.
In this session, we’ll discuss 10 specific strategic actions that Product Managers & Product Marketers can take to become more strategic in their role in a way that enables them to take ownership for driving revenue and success for their products.
What is the purpose of internal auditing? How important is it to the business? How are internal audits planned and carried out? These slides show the relevance of internal audit to the business, how internal audits relate to the objectives and risks of the business, how they are planned and the work involved in an internal audit. Further advice is available from www.internalaudit.biz
SharePoint Configuration Management – Effective Techniques for Regulated Shar...Montrium
This presentation will include:
• Recap of Validating SharePoint for Regulated Environments
• SharePoint within the GxP context
• Regulatory Requirements
• Industry Standards
• Corporate Standards
• What is Configuration Management?
• Implementation of formal system specific configuration control procedures
• Configuration deployment and version control techniques
• Integration with the validation and change control process
• Importance of leveraging a risk based approach to QC
• Using SharePoint to manage configuration control
Enjoy
If you have any questions please email info@montrium.com
This article will provide clarity on all below mentioned points,
FDA Audit - The Do and Don't List
How to Prepare for a FDA Inspection
FDA Basics for Industry > What should I expect during an inspection?
What to Expect When Being Inspected - FDA
FDA Inspections: Face the Challenge Through Proactive PreparationTips to Help You Prepare for an FDA Inspection
Inspection Readiness
US food and drug administration Indian site inspections: An experience
Dealing with a "difficult" FDA investigator
Strategies For Managing FDA Inspection Compliance Risks
Dear Readers,
Through PRES we are trying to connect with the Global Pharma community. Where we discussed, share and explore lots of pharmaceutical hot topics. Being a Pharma professional it is very difficult to get time for own to do something different other than routine responsibilities. Hope you all paraprofessionals are agreed with my views.
That’s you, the readers and followers of my blog, who always encouraged me a lot to do something different than my routine schedule. All the information are easily available web media, I am just trying too collate all those information in a single article.
I have collated the information’s broadly from the Pharmacompliancemonitor, FDA and other regulatory website for this article.
Once again I would like to thanks my readers, followers and seniors, who has encourage me a lot.
PRES Mission
To develop scientifically sound, practical, technical information and resources to advance science and regulation for the pharmaceutical industry
PRES Vision
To be the foremost global provider of science, technology, and regulatory information and education for the pharmaceutical community
Change Management in Pharmaeutical Manufacturing Operations (Full Day Session)Obaid Ali / Roohi B. Obaid
InshaAllah will be delivered tomorrow (04 Aug 2018) in a workshop of about 30 participants (Professionals engaged in Pharmaceutical Manufacturing, Engineering, Regulatory & Quality Operations)
A structured approach to the investigation process should be used with the objective of determining the root cause.
The level of effort, formality, and documentation of the investigation should be commensurate with the level of risk, in line with ICH Q9.
Managing Process Scale-up and Tech Transfer MilliporeSigma
Are you involved with planning tech transfer of your drug product? Join this webinar to learn more about the regulations and considerations you need to consider and learnings from a case study.
According to ICH Q10, “The goal of technology transfer activities is to transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realization. This knowledge forms the basis for the manufacturing process, control strategy, process validation approach, and ongoing continual improvement.”
As a result, there is an expectation for transfers to be performed in an organized, methodical manner with appropriate documentation. It is also expected that they happen between one Process Development group to another or to a Pilot Lab, from Process Development lab to clinical or commercial manufacturing, or from Process Development to external clinical manufacturing. Lastly, they may also happen between two company facilities at commercial scale, or between a company and an external contract manufacturing at commercial scale.
This presentation will cover points to consider for successful tech transfers with a focus on cGMP training requirements, and include lesson learned from real cases.
Presented by Guillaume Plane on September 22, 2016
Quality Management system in accordance to Vol. 4 EU Guidelines for GMP for Medicinal Products for Human and Veterinary Use Chapter 1 Pharmaceutical QS
ICH Q10/ Q7.
ISO 9001/2015
The 10 Most Important Levers of Control That All Product Managers and Product...CompellingPM
Way too often, Product Managers & Product Marketers make the excuse that they cannot take ownership for the success of their product in the market because there are too many factors outside to their control. While many Product Managers/Marketers complain about these limitations, Great Product Managers & Marketers become Strategic and take ownership of the success of their products.
In this session, we’ll discuss 10 specific strategic actions that Product Managers & Product Marketers can take to become more strategic in their role in a way that enables them to take ownership for driving revenue and success for their products.
What is the purpose of internal auditing? How important is it to the business? How are internal audits planned and carried out? These slides show the relevance of internal audit to the business, how internal audits relate to the objectives and risks of the business, how they are planned and the work involved in an internal audit. Further advice is available from www.internalaudit.biz
SharePoint Configuration Management – Effective Techniques for Regulated Shar...Montrium
This presentation will include:
• Recap of Validating SharePoint for Regulated Environments
• SharePoint within the GxP context
• Regulatory Requirements
• Industry Standards
• Corporate Standards
• What is Configuration Management?
• Implementation of formal system specific configuration control procedures
• Configuration deployment and version control techniques
• Integration with the validation and change control process
• Importance of leveraging a risk based approach to QC
• Using SharePoint to manage configuration control
Enjoy
If you have any questions please email info@montrium.com
To obtain a position within the Biotech arena that will enable me to use my strong organizational skills, educational background and ability to work well with people.
1. Nital M. Rami
836 Crystal Palace Court
Owings Mills, MD 21117
Home # (410) 902-7146, Cell # (443) 929-2944
nmrami@yahoo.com
Operating Skills:
• Closed Cycle Utility Spray Dryer ▪ Versifeeder
• Nice Spheronizer S-450 ▪ Solution Preparation.
• Sweco (Vibro-Energy) Separator LS-24, LS-48 ▪ PC 6/8
• Quadro comil 196-s, 194-s ▪ Bosch H&K Encapsulator
• IR-100 Moisture Analyzer ▪ Accufeeder
• Bin Blender ▪ Ohara Coating Pan
• Microsoft Office Suite
EXPERIENCE:
PHARMACEUTICS INTERNATIONAL INCORPORATED (PII) Hunt
Valley, MD
Senior Quality Assurance Associate-Batch Record Review, Release and/or Rejection (Aug.
2011- Present)
• Review and interprets Batch Record Documentation/Packaging Record
Documentation and related materials in accordance with SOPs and statutory
governing regulations in order to expedite and execute product release
● Initiates correction of errors and omissions, and assists in performing product investigations,
i.e.,
component reconciliation, as required.
• Respond to client observations relating to executed batch records reviewed.
• Assist in performing investigations involved with batch record reviews and raw materials, as
required.
• Issue “Release”, “Hold”, and/or “Rejected” Status Labels, as required and applicable.
• Initiate product “re-sampling” and finished product release “re-stickering”, as required.
• Review Quality Assurance (QA) paperwork for correctness to be incorporated in the batch
record.
• Performs “Finished Product Review” of batch records to ensure that all “Line
Clearance”, “Weighing Sheets”, Room and Equipment Labeling/Status Indicators”,
packaging components, etc., are present, signed, and dated, along with
corresponding Quality Assurance (QA) inspection paperwork.
• Ensures that any deviations, investigations, Out-of-Specifications” (OOS)
Reports, as they relate to the batch, are identified and addressed in a timely and
accurate manner.
• Review Analytical Laboratory Reports for raw materials, in-process materials, and
finished product, ensuring that all have been properly signed, verified, and
approved, as per SOPs.
• Review and disposition Raw Materials and executed batch records for “Release”,
“Hold”, and/or “Rejection” and issues Status Labels, as required.
2. PHARMACEUTICS INTERNATIONAL INCORPORATED (PII) Hunt
Valley, MD
Quality Assurance Associate- Inspector (Jan. 2010-
Aug. 2011)
• Perform “Line Clearance” and “Cleaning Verification” for manufacturing and
packaging operations per established Standard Operating Procedures (SOPs),
Batch/Packaging, and Labeling Records’ requirements.
• Perform in-process sampling, inspections, testing and batch record reviews
during manufacturing and packaging operations as per established SOPs and
Batch/Packaging and Labeling Records’ requirements.
• Perform Acceptable Quality Level (AQL) sampling and testing as required for in
process and finished product.
• Participate in the preparation for sampling, actual submission of samples to
Quality Control (QC), and disposition of samples for Cleaning Verification.
• Perform inspection of cGMP and non-cGMP areas for compliance to policies and
procedures as written approved.
• Perform daily systems verifications including, but not limited to, recording and
reporting of magnehelic gauge data and water system data and the disposition
of the systems.
• Participate in and support Annual Product Reviews (APRs).
• Submit product samples for analytical testing as required.
• Create storage systems for storage and retrieval of retain samples, as required.
• Perform investigational activities and prepare Incident Reports, Investigation
Reports, and Planned Deviation Reports, as assigned.
• Review quality systems, including policies and procedures, and recommend
improvements, affecting compliance and efficiencies.
• Engage in planning activities to provide for effective support of manufacturing
and packaging operations.
SHIRE PHARMACEUTICALS, INC. Owings
Mills, MD
Quality Engineer (11/2008 –
06/2009)
• Maintain awareness of manufacturing activities by routine direct observation.
• Provide guidance/direction on “Visual Factory” management related to quality
metrics
• Review CAPA effectiveness evaluation based on quantitative and qualitative
measurements
• Perform batch record review & release.
• Lead and participate in site quality and process improvement initiatives, and
project teams.
• Properly investigate and explain observations/non-conformances.
• Perform intermediate drug product disposition
• Represents QA on new project and improvement teams by qualifying new
suppliers, setting
• Quality/compliance requirements, developing Sop’s, approving specifications and
providing
• Provide technical transfer/validation support.
• Performed visual inspection & swabbing of TOC & HPLC equipment.
3. Quality Assurance Associate (08/2006—
11/2008)
• Perform batch record review & release in an efficient and timely manner;
including double-checking calculations to assure that are correct.
• Properly investigate and explain observations/non-conformances.
• Review and evaluate Quality Control results for raw materials, intermediates and
finished product.
• Track and evaluate any non-conformances that occur during the manufacture of
cGMP material.
• As necessary, escalate to the manager’s attention and aid in requesting a more
extensive investigation.
• Accurately calculate expiration dates of cGMP material, assuring that products
are not released for human consumption with incorrect or expired dating.
• Communicate with other departments within Shire, as well as with personnel at
contractor sites, on Quality and compliance issues. Effectively communicate
possible bath record and cGMP deficiencies to various manufacturing sites.
• Support any QA investigation involving customer complaints.
• Stay current with changes to the Code of Federal Regulations (CFR) or FDA
guidance documents.
• Create training modules and assist with the training of new QA personnel.
• Participate in internal cGMP audits & Provide backup for raw material releases.
• Knowledge of statistical methods for quality assurance, i.e. .capable of Six-Sigma
skills, Must be a highly motivated, detail-oriented individual who possesses
excellent organization and solving skills.
• Working knowledge of databases, including SAP, Access, spreadsheet
applications, Microsoft Project, Minitab and word processing to perform
necessary tasks for preparing required data analysis.
OE Batch Record Review
(08/2005 – 08/2006)
• Review manufacturing batch records.
• Assure the batch records are complete and accurate
• Ensure completion of QNs, and CAPAs, as appropriate to the record
• Perform label reconciliation
• Review and address comments to ensure completeness
• Complete and ensure Batch Record Review Forms for all observations.
Process Operator II
(04/2001 –08/2005)
• Full working knowledge of pan coating, cycle utility spray dryer including set-up,
operation and troubleshooting.
• Full working knowledge of Microsoft Office computer software.
• Full compliance with cGMP, SOP and safety standards.
• Complete and maintain a variety of documents required of a cGMP operation.
• Execute projects, tasks and follow detailed directions.
• Use knowledge of equipment in determining an effective plan to complete
assigned tasks.
4. • Full working knowledge of Fluid-Bed Processor for drying coating and drug
layering.
• Extensive solution preparation experience involving aqueous and organic solvent
for
Immediate, modified sustained and enteric release coating.
EDUCATION:
1990 – 1994 Bachelor of Arts, Anand Arts College, India
1994 Diploma in Office Computer, India
2000 Successfully completed course in Keyboard Skills, Baltimore, MD
2001 Training course in Medical Billing, Timonium, MD